KLF6 was implicated as a novel regulator of hepatic glucose and lipid metabolism in non-alcoholic fatty liver disease, characterized by dysregulated glucose homeostasis [42]. Here, KLF6 is linked to metabolic dysfunction-associated steatotic liver disease.